Precision medicine

Lung cancer patients can’t always wait for treatment – so rapid in-house NGS can facilitate precision therapy fast

Rapid, reliable, widespread whole genome sequencing could shorten the rare disease diagnostic odyssey and improve patients’ lives

Overcoming lung cancer treatment resistance requires predictive biomarkers that take into account patient variability

In an aging world with cancer cases increasing, it’s time for technology

Size isn’t everything when it comes to next-generation sequencing. For one NHS consortium, using multiple panels is changing the game

Not all patients respond to cancer immunotherapy – so how can we identify those who won’t and seek out better treatment options for them?

Do you know how to choose the right panel size when providing NGS testing for cancer patients?

Download our new e-book for a quick overview of hot topics in cancer research, diagnosis, and treatment

The latest update to the 21st Century CURES Act gives patients unprecedented access to their data

A new biosensor facilitates urinary detection of early responses to immune checkpoint blockade inhibitors